课题基金 / 基金详情

Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging

Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
癌症和衰老中内分泌和心脏代谢异常的指导
批准号:
10652585
负责人:
Shehzad Basaria
金额:
$18.91万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-15 至 2026-04-30
关键词:
AddressAgeAgingAmericanAndrogensAreaAwardBaltimoreBenefits and RisksBostonCancer BurdenCapsicumCardiometabolic DiseaseCaringCastrationClinicalClinical ResearchClinical TrialsColorectal CancerDataDepositionDeteriorationDiabetes MellitusDiagnosisDiseaseEndocrineEndocrine System DiseasesEndocrinologistEndocrinologyEnrollmentEnvironmentErythropoiesisFacultyFatigueFatty LiverFatty acid glycerol estersFosteringFunctional disorderFundingGeneral PopulationGeriatricsGoalsGrantHealthHigh PrevalenceHospitalsHypogonadismIncidenceInfiltrationInflammationInflammatoryInfrastructureInstitutionInsulin ResistanceInternationalInvestigationK-Series Research Career ProgramsLongitudinal StudiesLower ExtremityMagnetic Resonance SpectroscopyMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMeasuresMedicalMedicineMentorsMentorshipMetabolicMetabolic syndromeMetabolismMetastatic Prostate CancerMid-Career Clinical Scientist Award (K24)Morbidity - disease rateMuscleOncologyParticipantPhysical FunctionPhysical PerformanceProductivityProstateResearchResearch InstituteResearch PersonnelResearch SupportResourcesRoleScienceSeriesSkeletal MuscleTestosteroneThinnessTimeTissuesTrainingTranslational ResearchUnited StatesUnited States National Institutes of HealthUpper ExtremityUrologyWomanWorkage relatedandrogen deprivation therapycardiometabolic riskcardiometabolismcareerclinical centerclinical investigationcytokinedisabling symptomfrailtyimprovedinterestmedical schoolsmedical specialtiesmenmid-career facultymultidisciplinarymuscle formmuscle strengthnext generationnovelolder menpatient oriented researchprogramsprospectiveprostate cancer survivorsreduced muscle strengthside effectskills

项目摘要

项目成果

Shehzad Basaria的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Shehzad Basaria, MD, an Associate Professor of Medicine and Endocrinology in the Division of Endocrinology, Diabetes, & Metabolism at Brigham and Women's Hospital, Harvard Medical School, submits this application for a K24 Mid-Career Development award to provide protected time to mentor trainees in Patient-Oriented Research (POR) in Endocrine aspects of Gero-Oncology. Dr. Basaria is one of the few endocrinologists worldwide specializing in endocrine and cardio-metabolic disorders in older men with cancer and androgen deficiency. He will pursue additional training to hone his mentoring skills in order to build on his established record of mentorship and foster the research careers of early investigators. Candidate: Dr. Basaria is a highly productive clinical researcher in the field of Endocrinology, Aging and Cancer. Since 2003, he has been continuously NIH-funded to investigate: i) endocrine and cardio-metabolic complications of androgen deprivation therapy (ADT) in men with prostate cancer (PCa), ii) benefits and risks of androgen replacement in older men, and iii) endocrinology of aging. He has conducted his investigations using NIH-supported infrastructure, including RO1s and R21 grants, data from the Baltimore Longitudinal Study of Aging (BLSA), the InChianti Study, and the Boston Pepper Center for Function-Promoting Therapies. With his uncommon skill set and strong POR program in Endocrinology and Gero-Oncology, he has been a sought-after collaborator and mentor at Brigham/Harvard and at national and international institutions. Mentoring Plan/Environment: This application will leverage the extensive training resources at Brigham/Harvard, including the Center for Clinical Investigation, the Brigham Research Institute for Clinical and Translational Research, and T32 training grants in a variety of specialties. It will also draw on the unparalleled resources of the Boston Pepper Center and other funded studies to serve as a platform for POR trainees at multiple levels. Research Plan: The novel research supported by this K24 award will make significant contributions to the 1A) The impact of ADT-induced profound hypogonadism and the resulting decline in muscle mass on physical function, 1B) The impact of ADT on fat infiltration of skeletal muscles and the association of this deterioration in muscle quality on physical function, and 2) The mechanisms by which testosterone replacement improves Cancer- Related Fatigue in older men with cancer. understanding of the impact of androgen deficiency in older men with cancer in three major areas: These novel aims will build on the ongoing work in Dr. Basaria's current R01s, explore new hypotheses, and expand opportunities for trainees.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Failure of Androgen-Deprivation Therapy Due to Ectopic hCG Secretion.
由于异位 hCG 分泌导致雄激素剥夺治疗失败。
DOI: 10.1056/nejmc2213461
发表时间: 2023
期刊: The New England journal of medicine
影响因子: --
作者: [Gagliano-Jucá,Thiago, Hirsch,MichelleS, McGregor,BradleyA, Basaria,Shehzad]
通讯作者: Basaria,Shehzad
Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
  • 批准号:
    10469444
  • 项目类别:
  • 资助金额:
    $19.23万
  • 财政年份:
    2021
  • 负责人:
    Shehzad Basaria
  • 依托单位:
Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women with Chronic Pain and Opioid Use
  • 批准号:
    10413965
  • 项目类别:
  • 资助金额:
    $22.38万
  • 财政年份:
    2021
  • 负责人:
    Shehzad Basaria
  • 依托单位:
Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
  • 批准号:
    10300180
  • 项目类别:
  • 资助金额:
    $18.48万
  • 财政年份:
    2021
  • 负责人:
    Shehzad Basaria
  • 依托单位:
Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women with Chronic Pain and Opioid Use
  • 批准号:
    10189910
  • 项目类别:
  • 资助金额:
    $26.85万
  • 财政年份:
    2021
  • 负责人:
    Shehzad Basaria
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: